loader
Please Wait
Applying Filters...
menu
    • menu

    Technical details about Anagliptin, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Anagliptin

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 739366-20-2, Suiny, Sk-0403, Anagliptin [inn], (s)-n-(2-((2-(2-cyanopyrrolidin-1-yl)-2-oxoethyl)amino)-2-methylpropyl)-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide, Cwp-403
    Molecular Formula
    C19H25N7O2
    Molecular Weight
    383.4  g/mol
    InChI Key
    LDXYBEHACFJIEL-HNNXBMFYSA-N
    FDA UNII
    K726J96838
    Anagliptin is an orally available, potent, selective inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Compared to vildagliptin, anagliptin caused longer lasting inhibition of DPP-4 activity.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    N-[2-[[2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]amino]-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide
    2.1.2 InChI
    InChI=1S/C19H25N7O2/c1-13-7-16-21-9-14(11-26(16)24-13)18(28)22-12-19(2,3)23-10-17(27)25-6-4-5-15(25)8-20/h7,9,11,15,23H,4-6,10,12H2,1-3H3,(H,22,28)/t15-/m0/s1
    2.1.3 InChI Key
    LDXYBEHACFJIEL-HNNXBMFYSA-N
    2.1.4 Canonical SMILES
    CC1=NN2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N3CCCC3C#N
    2.1.5 Isomeric SMILES
    CC1=NN2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N
    2.2 Other Identifiers
    2.2.1 UNII
    K726J96838
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. (s)-n-(2-((2-(2-cyanopyrrolidin-1-yl)-2-oxoethyl)amino)-2-methylpropyl)-2-methylpyrazolo(1,5-a)pyrimidine-6-carboxamide

    2. Anagliptin Hydrochloride

    3. N-(2-((2-((2s)-2-cyanopyrrolidin-1-yl)-2-oxoethyl)amino)-2-methylpropyl)-2-methyl Pyrazolo(1,5-a)pyrimidine-6-carboxamide Hydrochloride

    2.3.2 Depositor-Supplied Synonyms

    1. 739366-20-2

    2. Suiny

    3. Sk-0403

    4. Anagliptin [inn]

    5. (s)-n-(2-((2-(2-cyanopyrrolidin-1-yl)-2-oxoethyl)amino)-2-methylpropyl)-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide

    6. Cwp-403

    7. N-[2-[[2-[(2s)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]amino]-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide

    8. Chembl1929396

    9. Pyrazolo(1,5-a)pyrimidine-6-carboxamide, N-(2-((2-((2s)-2-cyano-1-pyrrolidinyl)-2-oxoethyl)amino)-2-methylpropyl)-2-methyl-

    10. K726j96838

    11. Chembl1929387

    12. Unii-k726j96838

    13. N-(2-((2-((2s)-2-cyanopyrrolidin-1-yl)-2-oxoethyl)amino)-2-methylpropyl)-2-methylpyrazolo(1,5-a)pyrimidine-6-carboxamide

    14. N-[2-({2-[(2s)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide

    15. Anagliptin [mi]

    16. Anagliptin (jan/inn)

    17. Anagliptin [jan]

    18. Anagliptin [who-dd]

    19. Schembl905393

    20. Gtpl11582

    21. Chebi:136043

    22. Dtxsid401045689

    23. Bdbm50359366

    24. Mfcd19443729

    25. S5909

    26. Sk0403

    27. Zinc70647144

    28. Akos027325601

    29. Cs-4510

    30. Db12417

    31. Compound 4a [pmid: 22019046]

    32. Ncgc00484798-01

    33. Hy-14877

    34. D09780

    35. A916481

    36. Q15269682

    2.4 Create Date
    2009-12-22
    3 Chemical and Physical Properties
    Molecular Weight 383.4 g/mol
    Molecular Formula C19H25N7O2
    XLogP30
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count6
    Rotatable Bond Count6
    Exact Mass383.20697307 g/mol
    Monoisotopic Mass383.20697307 g/mol
    Topological Polar Surface Area115 Ų
    Heavy Atom Count28
    Formal Charge0
    Complexity643
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Dipeptidyl-Peptidase IV Inhibitors

    Compounds that suppress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN and GLUCAGON secretion characteristic of TYPE 2 DIABETES MELLITUS by stimulating insulin secretion and suppressing glucagon release. (See all compounds classified as Dipeptidyl-Peptidase IV Inhibitors.)